The effect of melatonin as an anti-convulsant and neurone protector;Efecto de la melatonina como anticonvulsivante y protector neuronal

Revista de Neurologia

Volumn 25, Issue 144, 1997, Pages 1229-1234

  Sanchez Forte M ^a,d   Moreno Madrid, F ^a   Munoz Hoyos A ^b   Molina Carballo, A ^b   Acuna Castroviejo D ^c   Molina Font, J A ^b  

^a Hospital General Basico de Baza   (Spain)

^b HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^c UNIVERSITY OF GRANADA   (Spain)

^d Hospital General Básico de Motril   (Spain)

Author keywords

Anti oxidant; Convulsion; Epilepsy; Melatonin

Indexed keywords

MELATONIN;

ANTICONVULSANT ACTIVITY; ARTICLE; CASE REPORT; CHILD; CIRCADIAN RHYTHM; EPILEPSY; FEMALE; HUMAN; NEUROPROTECTION; PINEAL BODY; SLEEP; ANIMAL; PHYSIOLOGY; RAT; REVIEW; SECRETION;

ANIMALS; EPILEPSY; FEMALE; HUMANS; MELATONIN; RATS;

EID: 0030611308     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (89)

1. Cipolla-Neto J. Marques N, Menna-Barreto LS, eds. Introduçao ao estudo da cronobiología. Sao Paulo: Icone; 1988.
2. Moore RY. The suprachiasmatic nucleus and the organization of a CNS circadian rhythm. Trends Neurosci 1983; 5: 404-7.
3. Pevet P. Environmental control of the annual reproductive cycle in mammals. Role of the pineal gland. Comp Physiol Environm Adapt 1987; 3: 82-100.
4. Reiter RJ. The melatonin message: duration versus coincidende hypotheses. Life Sci 1987; 40: 2119-31.
5. Cardinali DP. Melatonin. A mammaliam pineal hormona. Endocr Rev 1981; 2: 327-46.
6. Reiter RJ, Vaughan MK. Dynamic organization of endocrine networks: The neuroendocrine-reproductive axis and the pineal gland as examples. Ann NY Acad Sci 1991; 618: 11-27.
7. Illnerova H, Backstrom B, Saapf J, et al. Melatonin in rat pineal gland and serum, rapid parallel decline after light exposure at night. Neurosci Lett 1978; 9: 189-93.
8. Arendt J. Melatonin. Clin Endocrin 1988; 29: 205-29.
9. Lewy AJ, Wehr TA, Goodwin FK. Light suppresses melatonin secretion in humans. Science 1980; 210: 1267-9.
10. Smith JA, O'Hara J, Schiff AA. Altered diurnal serum melatonin rhythm in blind men. Lancet 1981; 24: 933.
11. Langdon-Down M, Brain WR. Time of day in relation to convulsions in epilepsy. Lancet 1929; 2: 1029.
12. Martins da Silva A, Binnie CD, Meinardi H, eds. Biorhythms and Epilepsy. New York: Raven Press; 1985.
13. Nagao H, Morimoto T, Takahashi M, et al. The circadian rhythm of typical absence seizures: the frequency and duration of paroxismal discharges. Neuropediatrics 1990; 21: 79-82.
14. Martins da Silva A, Aarts JHP, Binnie CD, et al. The circadian distribution on interictal epileptiform EEG activity. Electroenceph Clin Neurophysiol 1984; 58: 1-13.
15. Mikol F, Monge-Strauss MF. The timing of crisis and day-night distribution of paroxysmal EEG activities: a study on 197 epileptic patients. Rev Neurol (Paris) 1987; 143: 451-6.
16. Ehlers CL, Killam EK. The effects of constant light on EEG and seizure activity in the epileptic baboon. Electroenceph Clin Neurophysiol 1982; 54: 187-93.
17. Van Luijtelaar ELJM, Coenen AML. Circadian rhythmicity in absence epilepsy in rats. Epilepsy Res 1988; 2: 331-6.
18. Snead OC. γ-Hydroxybutyrate model of generalized absence seizures: further characterization and comparison with other absence models. Epilepsia 1988; 29: 361-8.
19. Aziz H, Francis P, Ali SM, Hasan Z. Epilepsy and photosensitivity. J Pak Med Assoc 1989; 39: 212-4.
20. Naquet R, Menini C, Riche D, et al. Photic epilepsy problems raised in man and animals. Ital J Neurol Sci 1987; 8: 437-47.
21. Silva-Barrat C, Brailowsky S, Levesque G, Menini C. Epileptic discharges induced by intermittent light stimulation in photosensitive baboons: a current source density study. Epilepsy Res 1988; 2: 1-8.
22. Danesi MA. Seasonal variations in the incidence of photoparoxysmal response to stimulation among photosensitive epileptic patients: evidence from repeated EEG recondings. J Neurol Neurosurg Psychiatry 1988; 51: 875-7.
23. Trenite DG, Binnie CD, Oosting J, van Emde Boas W. Seasonal variations in the incidence of photoparoxysmal response. J Neurol Neurosurg Psychiatry 1989; 52: 547-8.
24. Winters WD, Hance AJ, Cadd GC, Lakin ML. Seasonal and sex influences on ketamine-induced analgesia and catalepsy in the rat; a possible role for melatonin. Neuropharmacology 1986; 25: 1095-101.
25. Reiter RJ, Morgan W. Attemps to characterize the convulsive response of parathyroidectomized rats to pineal gland removal. Physiol Behav 1972; 9: 203-8.
26. Fariello RG, Bubenik GA, Brown GM, Grota LJ. Epileptogenic action of intraventricular injected anti-melatonin antibody. Neurology 1977; 27: 567-70.
27. Zeise ML, Semm P. Melatonin lowers excitability of Guinea pig hippocampal neurons in vitro. J Comp Physiol 1985; 157: 23-9.
28. Reiter RJ, Sorrentino S. Hoffman RA. Muscular spasms and death in thyroparathyroidectomized rats subjected to pinealectomy. Life Sci 1972; 11: 123-33.
29. Philo R, Reiter RJ. Characterization of pinealectomy induced convulsions in the mongolian gerbil (Meriones unguicutatus). Epilepsia 1978; 19: 485-92.
30. Rudden PK, Philo SR, Sysmmes SK. Antiepileptic effects of melatonin in the pinealectomized mongolian gerbil. Epilepsia 1980; 21: 149-54.
31. Stockmeier CA, Blask DE. Pinealectomy-induced convulsions: current status a model of epilepsy. In RJ Reiter, M Karasek, eds. Advances in Pineal Research, vol 1. London: John Libbey; 1986. p. 197-206.
32. Albertson TE, Peterson SL, Stark LG, et al. The anticonvulsivant properties of melatonin on kindled seizures in rats. Neuropharmacology 1981; 20: 61-6.
33. Mikol F, Monge-Strauss MF. Horaires des crises et répartition nycémérale des activitiés EEG paroxystiques: etude chez 197 épileptiques. Rev Neurol (Paris) 1984; 143: 451-6.
34. Koch P, Soussignan R, Montagner H. Nuevos datos sobre el ritmo vigilia-sueño en niños de edades comprendidas entre 2 1/2 y 4 1/2 años. Acta Paediatr Scand 1984; 1: 701-7.
35. Ortiz Camuñez MA, Martin de Agar Y, Valverde MC, et al. EEG con privación de sueño en niños epilépticos. An Esp Ped 1984; 21: 191-7.
36. Anton-Tay F, Díaz JL, Fernández-Guardiola A. On the effect of melatonin upon human brain. Its possible therapeutic simplications. Life Sci 1971; 10: 841-50.
37. Anton-Tay F. Melatonin: effects on brain function. Adv Biochem Psychopharmac 1974; 11: 315-24.
38. Brueske V, Allen J, Kepic T, et al. Melatonin inhibition of seizure activity in man. Boston: American EEG Society; 1980.
39. Mendelson WB, Gillin JC, Dawson SD, et al. Effects of melatonin and propanolol on sleep of the rat. Brain Res 1980; 201: 240-4.
40. Satake N. Melatonin mediation in sedative effect of serotonin in goldfish. Physiol Behav 1979; 22: 817-9.
41. Anton-Tay F. Pineal-brain relationships. En Wolstenhokme GEN, Knight J, eds. The pineal gland. Londres: Churchill; 1971. p. 213-27.
42. Papavasiliov PS, Cotzias GC, Duby SE, et al. Melatonin and parkinsonism. JAMA 1972; 221: 88.
43. Erlich SS, Apuzzo MLJ. The pineal gland: anatomy, physiology and clinical significance. J Neurosurg 1985; 63: 321-41.
44. Vollrath L, Semm P, Gammel G. Sleep induction by intranasal application of melatonin. In Birau N, Schloot W, ed. Melatonin: Current Status and Perspectives. New York: Pergamon Press; 1981. p. 327.
45. Terman M, Terman JS, Quitkin FM, et al. Light therapy for seasonal affective disorder. A review of efficacy. Neuropsychopharmacology 1989; 2: 1-22.
46. Cotzias GC, Papvasiliov PS, Ginos J, et al. Metabolic modification of Parkinson's disease and of chronic manganese poisoning. In Degraff AC, Creger WP, eds. Ann Rev Med. California: Palo Alto; 1971. p. 305-26.
47. Menscewicz J, Linkowski O, Branchey L, et al. Abnormal 24 h pattern of melatonin secretion in depression. Lancet 1979; 2: 1362.
48. Almay BGL, Knorring L, von Wetteberg L. Melatonin in serum and urine in patients with idiopathic pain syndromes. Psychiatry Res 1987; 22: 179-91.
49. Maurizi CP. Could supplementary dietary tryptophan and taurine prevent epilectic seizures? Med Hypoth 1985; 18: 411-5.
50. Molina A, Acuña-Castroviejo D, Rodríguez Cabezas T, Muñoz Hoyos A. Melatonin circadian rhythm in normal children and in children with febrile and epileptic convulsions. J Endocrinol Invest 1989; 12 (Suppl 1): 102.
51. Molina A, Acuña-Castroviejo D, Rodríguez Cabezas T, Muñoz Hoyos A. Effect of febrile and epileptic convulsions on daily variation in plasma melatonin concentration in children. J Pineal Res 1994; 16: 1-9.
52. Molina A, Muñoz Hoyos A, Rodríguez Cabezas T, Acuña-Castroviejo D. Day/night variations in melatonin secretion by pineal gland during febrile and epileptic convulsions in children. Psychiatry Res 1994; 52: 273-83.
53. Molina A, Muñoz Hoyos A, Rodríguez Cabezas T, et al. Interaction between duration of convulsion, refractory postseizure period and melatonin levels. Neuroendocrinology 1990; 52 (Suppl 1): 102.
54. Champney TH, Sánchez Forte M, Muñoz Hoyos A, et al. Anticonvulsant effects of melatonin in humans: two case studies. Society for Neuroscience, 25th Annual Meeting (abstract). San Diego 1995. November 11-16.
55. Niles LP, Pickering DS, Arciszewski MA. Effects of chronic melatonin administration of GABA and diazepam binding in rat brain. J Neural Trams 1987; 70: 117-24.
56. Acuña-Castroviejo D, Lowenstein PR, Rosenstein R, Cardinali DP. Diurnal variations of benzodiazepine binding in rat cerebral cortex: disruption by pinealextomy. J Pineal Res 1986; 3: 101-9.
57. Acuña-Castroviejo D, Rosenstein RE, Romero HE, Cardinali DP. Changes in gamma-aminobutyric acid high affinity binding to cerebral cortex membrates after pinealectomy or melatonin administration to rats. Neuroendocrinology 1986; 43: 24-31.
58. Morton DJ. Effect of anticonvulsivant drugs in vitro on pineal gland indole metabolism in organ culture. Biochem Pharmacol 1985; 34: 3198-201.
59. Morton DJ. Effect of in vivo anticonvulsivant drugs on pineal gland indole metabolism in organ culture. Biochem Pharmacol 1986; 35: 1049-50.
60. Castillo Romero JL, Vives Montero F, Acuña-Castroviejo D. Pineal modulation of the rat caudate-putamen neuronal activity: roles of melatonin and vasotocin. J Pineal Res 1993; 15: 147-52.
61. 3H]flunitrazepam binding. Neuroreport 1993; 4: 987-90.
62. A receptors. Science 1995; 269: 977-81.
63. Champney H, Peterson SL. Circadian, seasonal, pineal, and melatonin influences on epilepsy. In Hing-Sing Yu, RJ Reiter, eds. Melatonin. Biosynthesis, physiological effects, and clinical applications. Boca Raton, Ann Arbor, London, Tokyo: CRC Press; 1993. p. 476-94.
64. Lapin IP, Prakhie IB, Kiseleva IP. Antagonism of seizures induced by the administration of the endogenous convulsant quinolinic acid into rat brain ventricles. J Neural Trams 1986; 65: 177-85.
65. Stone TW, Connick JH. Quinolinic acid and other kynurenines in the central nervous system. Neuroscience 1985; 15: 597-617.
66. Swartz KJ, During MJ, Freese A, Beal MF. Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors. J Neurosci 1990; 10: 2965-73.
67. Thompson JL, Holmes GL, Taylor GW, Feldman DR. Effects of kynurenic acid on amygdaloid kindling in the rat. Epilepsy Res 1988; 2: 302-8.
68. Singh L, Oles RJ, Tricklebank MD. Modulation of seizure susceptibility in the mouse by the strychnine-insensitive glycine recognition site of the NMDA receptor/ion channel complex. Br J Pharmacol 1990; 99: 285-88.
69. Birch PJ, Grossman CJ, Hayes AG. Kynurenate and FG9041 have both competitive and non-competitive antagonist actions at excitatory amino acid receptors. Eur J Pharmacol 1988; 151: 313-5.
70. Ganong AH, Cotman CW. Kynurenic acid and quinolinic acid act at N-methyl-D-aspartate receptors in the rat hippocampus. J Pharmacol Exp Ther 1986; 236: 293-9.
71. Herzog AG. A hypothesis to integrate partial seizures of temporal lobe origin and reproductive endocrine disorders. Epilepsy Res 1989; 3: 151-9.
72. Schacter SC. Hormonal considerations of women with seizures. Arch Neurol 1988; 45: 1267.
73. Hrboticky N, Leiter LA, Anderson GH. Menstrual cycle effects on the metabolism of tryptophan loads. Am J Clin Nutr 1989; 50: 46-52.
74. Isojarvi JIT, Pakarinen AJ, Ylipalosaari PJ, Myllyla VV. Serum hormones in male epileptic patients receiving anticonvulsant mediation. Arch Neurol 1990; 47: 670-6.
75. Rao ML, Stefan H, Bauer J. Epileptic but not psychogenic seizures are accompanied by simultaneous elevation of serum pituitary hormones and cortisol levels. Neuroendocrinology 1989; 49: 33-9.
76. Rao ML, Stefan H, Bauer J, Burr W. Hormonal changes in patients with partial epilepsy: attenuation of melatonin and prolactin circadian serum profiles. In Dreifus FE, Meinardi H, Stefan H, eds. Chronopharmacology in therapy of the epilepsies. New York: 1990. p. 55.
77. Vance G, Maywood E. Some reflections on the phylogeny and function of the pineal. Experientia 1989; 45: 903-9.
78. Tan DX, Chen LD, Poeggeler B, et al. Melatonin: a potent endogenous hydroxyl radical scavenger. Endocr J 1993; 1: 57-60.
79. Suranyi-Cadotte B, Lal S, Nair NPV, et al. Coexistence of central and peripheral benzodiazepine binding sites in the human pineal gland. Life Sci 1987; 40: 1537-43.
80. Kabuto MK, Namura I, Saitoh Y. Nocturnal enhancement of plasma melatonin could be suppresed by benzodiazepines in humans. Endocrinol Jpn 1986; 33: 405-14.
81. Reiter RJ. Functional pleiotropy of the neurohormone melatonin: antioxidant protection and neuroendocrine regulation. Frontiers Neuroendocrinol 1995; 16: 383-415.
82. Reiter RJ, Menéndez-Pelàez A, Poeggeler B, et al. The role of melatonin in the pathophysiology of oxigen radical damage. In Moller M, Pevet P, eds. Advances in pineal research, vol 8. London: John Libbey; 1994. p. 403-12.
83. Roush W. Can 'resetting' hormonal rhythms treat illness? Science 1995: 269:1220-1.
84. Reiter RJ. A summary of the evidences supporting melatonin's role as an antioxidant. J Pineal Res 1995; 14: 1-11.
85. Gotz ME, Kunig G, Riederer P, Yoydim MBH. Oxidative stress: free radical production in neural degeneration. Pharmacol Ther 1994; 63: 37-122.
86. Meister A. On the oxidant effect of ascorbic acid and glutathione. Biochem Pharmacol 1992; 44: 1905-15.
87. Packer L. Vitamine E is nature's master antioxidant. Sci Amer (Sci Med) 1994; 54-63.
88. Pieri C, Marra M, Moroni F, et al. Melatonin: a peroxyl radical scavenger more effective than Vitamine E. Life Sci 1994; 15: 271-6.
89. Tan DX, Poeggeler B, Reiter RJ, et al. Both physiological and pharmacological levels of melatonin reduce DNA adduct formation induced by the carcinogen safrole. Carcinogenesis 1994; 15: 215-8.